Microbial risk in pharmaceutical process is not limited to living microorganisms and intact microbial cells. Subcellular components from microorganisms remaining from the production process can be source of pyrogens, compromising product quality and patient safety as these substances are not eliminated by classical filtration or sterilization steps. The monocyte activation test performed with the PyroMAT™ System detects endotoxin and non-endotoxin pyrogens.
Mathilde Arnault
Merck
Research Scientist
Microbiological testing
Duration:24min
Language:English
Session 1:presented April 9, 2019
To continue reading please sign in or create an account.
Don't Have An Account?